top of page
  • Ann Tucker

Impact of CARES Telehealth Expansion on Access to OUD Treatment

Updated: Mar 4, 2022

CMS recently released two briefs that summarize access to opioid use disorder treatment under the telehealth expansion during the COVID-19 pandemic. In the first brief, researchers describe the sociodemographic and health condition characteristics among Medicare fee-for-service beneficiaries with OUD and by medication access, both before and after the COVID-19 pandemic and CARES Act implementation. In a second brief, researchers provided an overview of how access to medication-assisted treatment (MAT) for fee-for-service beneficiaries with opioid use disorder changed during the COVID-19 telehealth expansion.

1 view0 comments

Recent Posts

See All

SAMHSA (11/10) –– The Substance Abuse and Mental Health Services Administration is pleased to announce the release of the agency’s Interim Strategic Plan (ISP), which presents a new mission and vision

The White House budget office is reviewing a draft SAMHSA rule that would make permanent the COVID-19 methadone take-home waiver and define which patients with OUD are considered “stable” enough to re

bottom of page